Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors

IntroductionThe utilization of large-scale claims databases has greatly improved the management, accessibility, and integration of extensive medical data. However, its potential for systematically identifying comorbidities in the context of skin diseases remains unexplored.MethodsThis study aims to...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Qinmengge Li, Matthew T. Patrick, Sutharzan Sreeskandarajan, Jian Kang, J. Michelle Kahlenberg, Johann E. Gudjonsson, Zhi He, Lam C. Tsoi
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: Frontiers Media S.A. 2024-01-01
মালা:Frontiers in Immunology
বিষয়গুলি:
অনলাইন ব্যবহার করুন:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1309549/full
_version_ 1827387836134850560
author Qinmengge Li
Matthew T. Patrick
Sutharzan Sreeskandarajan
Jian Kang
J. Michelle Kahlenberg
J. Michelle Kahlenberg
Johann E. Gudjonsson
Zhi He
Lam C. Tsoi
Lam C. Tsoi
Lam C. Tsoi
author_facet Qinmengge Li
Matthew T. Patrick
Sutharzan Sreeskandarajan
Jian Kang
J. Michelle Kahlenberg
J. Michelle Kahlenberg
Johann E. Gudjonsson
Zhi He
Lam C. Tsoi
Lam C. Tsoi
Lam C. Tsoi
author_sort Qinmengge Li
collection DOAJ
description IntroductionThe utilization of large-scale claims databases has greatly improved the management, accessibility, and integration of extensive medical data. However, its potential for systematically identifying comorbidities in the context of skin diseases remains unexplored.MethodsThis study aims to assess the capability of a comprehensive claims database in identifying comorbidities linked to 14 specific skin and skin-related conditions and examining temporal changes in their association patterns. This study employed a retrospective case-control cohort design utilizing 13 million skin/skin-related patients and 2 million randomly sampled controls from Optum’s de-identified Clinformatics® Data Mart Database spanning the period from 2001 to 2018. A broad spectrum of comorbidities encompassing cancer, diabetes, respiratory, mental, immunity, gastrointestinal, and cardiovascular conditions were examined for each of the 14 skin and skin-related disorders in the study.ResultsUsing the established type-2 diabetes (T2D) and psoriasis comorbidity as example, we demonstrated the association is significant (P-values<1x10-15) and stable across years (OR=1.15-1.31). Analysis of the 2014-2018 data reveals that celiac disease, Crohn’s disease, and ulcerative colitis exhibit the strongest associations with the 14 skin/skin-related conditions. Systemic lupus erythematosus (SLE), leprosy, and hidradenitis suppurativa show the strongest associations with 30 different comorbidities. Particularly notable associations include Crohn’s disease with leprosy (odds ratio [OR]=6.60, 95% confidence interval [CI]: 3.09-14.08), primary biliary cirrhosis with SLE (OR=6.07, 95% CI: 4.93-7.46), and celiac disease with SLE (OR=6.06, 95% CI: 5.49-6.69). In addition, changes in associations were observed over time. For instance, the association between atopic dermatitis and lung cancer demonstrates a marked decrease over the past decade, with the odds ratio decreasing from 1.75 (95% CI: 1.47-2.07) to 1.02 (95% CI: 0.97-1.07). The identification of skin-associated comorbidities contributes to individualized healthcare and improved clinical management, while also enhancing our understanding of shared pathophysiology. Moreover, tracking these associations over time aids in evaluating the progression of clinical diagnosis and treatment.DiscussionThe findings highlight the potential of utilizing comprehensive claims databases in advancing research and improving patient care in dermatology.
first_indexed 2024-03-08T16:08:02Z
format Article
id doaj.art-0fbcd6f6234f491598f3c09a1839c789
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-08T16:08:02Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-0fbcd6f6234f491598f3c09a1839c7892024-01-08T04:28:41ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-01-011410.3389/fimmu.2023.13095491309549Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factorsQinmengge Li0Matthew T. Patrick1Sutharzan Sreeskandarajan2Jian Kang3J. Michelle Kahlenberg4J. Michelle Kahlenberg5Johann E. Gudjonsson6Zhi He7Lam C. Tsoi8Lam C. Tsoi9Lam C. Tsoi10Department of Biostatistics, University of Michigan, Ann Arbor, MI, United StatesDepartment of Dermatology, University of Michigan, Ann Arbor, MI, United StatesThe Center for Autoimmune Genomics and Etiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United StatesDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, United StatesDepartment of Dermatology, University of Michigan, Ann Arbor, MI, United StatesRheumatology, Internal Medicine, University of Michigan, Ann Arbor, MI, United StatesDepartment of Dermatology, University of Michigan, Ann Arbor, MI, United StatesDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, United StatesDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, United StatesDepartment of Dermatology, University of Michigan, Ann Arbor, MI, United StatesDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United StatesIntroductionThe utilization of large-scale claims databases has greatly improved the management, accessibility, and integration of extensive medical data. However, its potential for systematically identifying comorbidities in the context of skin diseases remains unexplored.MethodsThis study aims to assess the capability of a comprehensive claims database in identifying comorbidities linked to 14 specific skin and skin-related conditions and examining temporal changes in their association patterns. This study employed a retrospective case-control cohort design utilizing 13 million skin/skin-related patients and 2 million randomly sampled controls from Optum’s de-identified Clinformatics® Data Mart Database spanning the period from 2001 to 2018. A broad spectrum of comorbidities encompassing cancer, diabetes, respiratory, mental, immunity, gastrointestinal, and cardiovascular conditions were examined for each of the 14 skin and skin-related disorders in the study.ResultsUsing the established type-2 diabetes (T2D) and psoriasis comorbidity as example, we demonstrated the association is significant (P-values<1x10-15) and stable across years (OR=1.15-1.31). Analysis of the 2014-2018 data reveals that celiac disease, Crohn’s disease, and ulcerative colitis exhibit the strongest associations with the 14 skin/skin-related conditions. Systemic lupus erythematosus (SLE), leprosy, and hidradenitis suppurativa show the strongest associations with 30 different comorbidities. Particularly notable associations include Crohn’s disease with leprosy (odds ratio [OR]=6.60, 95% confidence interval [CI]: 3.09-14.08), primary biliary cirrhosis with SLE (OR=6.07, 95% CI: 4.93-7.46), and celiac disease with SLE (OR=6.06, 95% CI: 5.49-6.69). In addition, changes in associations were observed over time. For instance, the association between atopic dermatitis and lung cancer demonstrates a marked decrease over the past decade, with the odds ratio decreasing from 1.75 (95% CI: 1.47-2.07) to 1.02 (95% CI: 0.97-1.07). The identification of skin-associated comorbidities contributes to individualized healthcare and improved clinical management, while also enhancing our understanding of shared pathophysiology. Moreover, tracking these associations over time aids in evaluating the progression of clinical diagnosis and treatment.DiscussionThe findings highlight the potential of utilizing comprehensive claims databases in advancing research and improving patient care in dermatology.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1309549/fullepidemiologyclaimsskin diseasecomorbidityOptum
spellingShingle Qinmengge Li
Matthew T. Patrick
Sutharzan Sreeskandarajan
Jian Kang
J. Michelle Kahlenberg
J. Michelle Kahlenberg
Johann E. Gudjonsson
Zhi He
Lam C. Tsoi
Lam C. Tsoi
Lam C. Tsoi
Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors
Frontiers in Immunology
epidemiology
claims
skin disease
comorbidity
Optum
title Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors
title_full Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors
title_fullStr Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors
title_full_unstemmed Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors
title_short Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors
title_sort large scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors
topic epidemiology
claims
skin disease
comorbidity
Optum
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1309549/full
work_keys_str_mv AT qinmenggeli largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT matthewtpatrick largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT sutharzansreeskandarajan largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT jiankang largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT jmichellekahlenberg largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT jmichellekahlenberg largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT johannegudjonsson largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT zhihe largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT lamctsoi largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT lamctsoi largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors
AT lamctsoi largescaleepidemiologicalanalysisofcommonskindiseasestoidentifysharedanduniquecomorbiditiesanddemographicfactors